Substances included in the composition of cranberry juice can fight bacteria that have developed resistance to antibiotics.
Experts from Dartmouth University (USA) intend to develop an antibacterial drug on the basis of the cranberries.
The attention of scientists from the group of Professor Terry Camesano was attracted by the unusual property of cranberry juice, which come into contact with the bacteria Escherichia coli (E. coli). To cause infection, bacteria need to attach to the cell wall and form a biofilm. It turned out that in cranberry juice, E. coli can’t do.
Cranberry juice contains a group of compounds of proanthocyanidins (PAC), which inhibit the bacteria Escherichia coli to complete the process of infection. This property of cranberry juice for all strains of E. coli that cause urinary tract infections, food poisoning, peritonitis, vaginitis, prostatitis, gastroenteritis, meningitis, mastitis, and even sepsis.
According to scientists, the substances included in the composition of cranberry juice can fight bacteria that have developed resistance to antibiotics.
